
    
      This randomized clinical trial assesses both the safety and efficacy of atypical
      antipsychotic agents in antipsychotic-naive aggressive children with various childhood
      psychiatric disorders during 12 weeks of prospective, randomized treatment with olanzapine,
      risperidone or aripiprazole.

      Aim 1: To evaluate effects of selected antipsychotic treatments on insulin action in muscle
      (glucose disposal), liver (glucose production) and adipose tissue (lipolysis).

      Aim 2: To evaluate effects of selected antipsychotic treatments on abdominal fat mass, total
      body fat and total fat-free mass.
    
  